Mizuho Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$39.5K 46
2024
Q3
$39.5K Buy
200
+100
+100% +$18.7K 0.1% 61
2024
Q2
$17.2K Buy
+100
New +$16.6K 0.04% 75
2024
Q1
Sell
-1,800
Closed -$279K 59
2023
Q4
$279K Buy
1,800
+1,760
+4,400% +$257K 1% 23
2023
Q3
$5.96K Sell
40
-410
-91% -$60.2K 0.03% 61
2023
Q2
$60.6K Sell
450
-740
-62% -$109K 0.14% 51
2023
Q1
$190K Buy
1,190
+610
+105% +$93.3K 0.59% 31
2022
Q4
$93.7K Sell
580
-7,881
-93% -$1.21M 0.26% 49
2022
Q3
$1.14M Buy
8,461
+4,580
+118% +$657K 0.38% 13
2022
Q2
$525K Buy
3,881
+3,451
+803% +$527K 0.1% 25
2022
Q1
$70K Sell
430
-1,192
-73% -$173K 0.02% 74
2021
Q4
$220K Buy
1,622
+1,181
+268% +$140K 0.08% 38
2021
Q3
$48K Buy
441
+371
+530% +$42.4K 0.01% 74
2021
Q2
$8K Sell
70
-9
-11% -$1.01K ﹤0.01% 103
2021
Q1
$9K Sell
79
-24
-23% -$2.57K ﹤0.01% 84
2020
Q4
$11K Buy
+103
New +$9.9K ﹤0.01% 83
2019
Q1
Sell
-900
Closed -$83K 119
2018
Q4
$83K Buy
+900
New +$79.1K 0.01% 50

Other funds holding ABBV

Mizuho Securities's ABBV Position: Q4 2024 in Review

Mizuho Securities sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 200 shares — an estimated $39.5K sold.

Mizuho Securities first reported a position in ABBV in Q4 2018 and held it in 16 quarters. The position peaked at $1.14M in Q3 2022. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Mizuho Securities reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Mizuho Securities sold 200 AbbVie shares in Q4 2024, an estimated $39.5K.
  • Mizuho Securities first reported a position in AbbVie in Q4 2018 and held it in 16 quarters.
  • Mizuho Securities's AbbVie position peaked at $1.14M in Q3 2022.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Mizuho Securities's 13F filing for Q4 2024, filed 12 Feb 2025.